A Risk Score Using a Cell-based Assay Predicts Long-term Over-immunosuppression Events in Kidney Transplant Recipients
Using a combination of age and in vitro PBMC response to Epstein-Barr virus peptides allows a substantial shift in the estimated risk of OIS events.
Authors
- Julie Lesage (ORCID: https://orcid.org/0000-0002-9186-5290)
- Isabelle Lapointe
- Jean-Simon Desgagnés
- Sacha A. De Serres (ORCID: https://orcid.org/0000-0002-7862-4935)
- Stéphanie Béland (ORCID: https://orcid.org/0000-0001-5313-9354)
- Alcino Gama (ORCID: https://orcid.org/0000-0002-0912-8268)
- Olivier Désy
- Marie-Pier Thivierge
- Isabelle Houde
- Isabelle Côté (ORCID: https://orcid.org/0000-0002-8360-9086)
- François Bouchard-Boivin (ORCID: https://orcid.org/0000-0002-7857-2354)
Institutions
- Université Laval (CA)
Publication Details
- Journal
- Transplantation
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1097/tp.0000000000005279
- Citations
- 1
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.51